Table 5.
Discounted 20-year lifetime direct medical costs
aAEs considered were: anemia, asthenia or fatigue, cardiac events (including heart failure), deep vein thrombosis, edema, gastrointestinal symptoms, herpes zoster, hyperglycemia, infections, neutropenia, peripheral neuropathy, rash, renal failure, and thrombocytopenia.
Abbreviations: AEs, adverse events; MP, melphalan and prednisone; MPR-R, MP plus lenalidomide with lenalidomide maintenance; MPT, MP plus thalidomide; PD, progressive disease; SL, second-line therapy; TF, treatment-free interval; VMP, bortezomib plus MP.